ACCELERATE (Completed)
Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High Risk for Vascular Outcomes (HRVD) – the ACCELERATE Study
- Medicine
- evacetrapib
- Population
- ASCVD
- Phase
- III
- Starting year
- 2012
- More information
- ClinicalTrials.gov